Finance

Lists
Why is 3378 down 3,02%?
Dive Deeper
3378:HKG
Hanx Biopharmaceuticals (Wuhan) Co Ltd
27,02 HK$
-3,02%
(-0,84) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3378...
Open
27,92 HK$
High
27,98 HK$
Low
27,02 HK$
Mkt. cap
3,62 млрд
Avg. vol.
8,22 мың
Volume
3,70 мың
52-wk high
33,80 HK$
52-wk low
13,48 HK$
Shares outstanding
136,22 млн
No. of employees
60
Open
27,92 HK$
High
27,98 HK$
Low
27,02 HK$
Mkt. cap
3,62 млрд
Avg. vol.
8,22 мың
Volume
3,70 мың
52-wk high
33,80 HK$
52-wk low
13,48 HK$
Shares outstanding
136,22 млн
No. of employees
60
News stories
From web sources and news partners
About Hanx Biopharmaceuticals (Wuhan) Co Ltd
CEO-
Employees60
Founded2014
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. нау.
2025 ж. мау.
2026 ж. нау.
2026 ж. мау.
Revenue
12,50 мың
12,50 мың
3,00 мың
3,00 мың
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,66 млн
15,66 млн
13,05 млн
13,05 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,03 млн
13,03 млн
13,96 млн
13,96 млн
Operating expense
28,66 млн
28,66 млн
26,82 млн
26,82 млн
Total operating expenses
28,66 млн
28,66 млн
26,82 млн
26,82 млн
Operating income
-28,65 млн
-28,65 млн
-26,81 млн
-26,81 млн
Other non operating income
-190,50 м.
-190,50 м.
-8,75 млн
-8,75 млн
EBT including unusual items
-29,00 млн
-29,00 млн
-22,47 млн
-22,47 млн
EBT excluding unusual items
-31,44 млн
-31,44 млн
-33,05 млн
-33,05 млн
Income tax expense
-12,17 млн
-12,17 млн
-5,85 млн
-5,85 млн
Effective tax rate
41,97%
41,97%
26,02%
26,02%
Other operating expenses
-24,50 мың
-24,50 мың
-191,00 м.
-191,00 м.
Net income
-18,22 млн
-18,22 млн
-18,44 млн
-18,44 млн
Net profit margin
-145 760,00%
-145 760,00%
-614 716,67%
-614 716,67%
Earnings per share
-
-
-
-
Interest and investment income
163,50 м.
163,50 м.
3,03 млн
3,03 млн
Interest expense
-2,77 млн
-2,77 млн
-519,50 м.
-519,50 м.
Net interest expenses
-2,60 млн
-2,60 млн
2,51 млн
2,51 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,15 млн
-28,15 млн
-26,09 млн
-26,09 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары